
- Telehealth Visits
- Insurance plan information


Carson Moseley, MD
Neurology • Neuroimmunology- Telehealth Visits
- Insurance plan information




Carson Moseley, MD
Neurology • Neuroimmunology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Neuroimmunology, UCSF Graduate Medical Education
Residency
- Neurology, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, University of Alabama School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223130%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223130%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 10 reviews
- January 29, 20265 out of 5 Stars
Good
- October 23, 20255 out of 5 Stars
Dr Mosley is the only Dr who has cared enough about my problems to try to find a solution and diagnosis for me.
- October 16, 20255 out of 5 Stars
Dr. Moseley is the best, caring M.S. Doctor That I have has the pleasure working with.
- October 11, 20255 out of 5 Stars
Dr Moseley is always great! He always allows space for me to comment and ask questions. And he responds with care and sincerity.
- April 19, 20255 out of 5 Stars
This is the first time to where a provider listened and actually was able to help me move forward with my care.
- October 20, 20245 out of 5 Stars
Dr. Moseley was very concerned, empathetic, and kind in the way handled my situation. I appreciate the way he cared for me.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.